- Home
- GLDD vs RAPP Comparison
GLDD vs RAPP Comparison
Compare GLDD & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDD
- RAPP
- Stock Information
- Founded
- GLDD 1890
- RAPP 2022
- Country
- GLDD United States
- RAPP United States
- Employees
- GLDD N/A
- RAPP N/A
- Industry
- GLDD Military/Government/Technical
- RAPP
- Sector
- GLDD Industrials
- RAPP
- Exchange
- GLDD Nasdaq
- RAPP Nasdaq
- Market Cap
- GLDD 829.6M
- RAPP 844.6M
- IPO Year
- GLDD 2006
- RAPP 2024
- Fundamental
- Price
- GLDD $11.64
- RAPP $18.46
- Analyst Decision
- GLDD Buy
- RAPP Strong Buy
- Analyst Count
- GLDD 1
- RAPP 4
- Target Price
- GLDD $14.00
- RAPP $37.33
- AVG Volume (30 Days)
- GLDD 408.4K
- RAPP 137.5K
- Earning Date
- GLDD 02-12-2025
- RAPP 02-10-2025
- Dividend Yield
- GLDD N/A
- RAPP N/A
- EPS Growth
- GLDD N/A
- RAPP N/A
- EPS
- GLDD 0.87
- RAPP N/A
- Revenue
- GLDD $741,648,000.00
- RAPP N/A
- Revenue This Year
- GLDD $33.01
- RAPP N/A
- Revenue Next Year
- GLDD $6.88
- RAPP N/A
- P/E Ratio
- GLDD $13.34
- RAPP N/A
- Revenue Growth
- GLDD 33.74
- RAPP N/A
- 52 Week Low
- GLDD $6.55
- RAPP $16.55
- 52 Week High
- GLDD $12.89
- RAPP $29.74
- Technical
- Relative Strength Index (RSI)
- GLDD 40.95
- RAPP N/A
- Support Level
- GLDD $11.30
- RAPP N/A
- Resistance Level
- GLDD $11.97
- RAPP N/A
- Average True Range (ATR)
- GLDD 0.41
- RAPP 0.00
- MACD
- GLDD -0.12
- RAPP 0.00
- Stochastic Oscillator
- GLDD 21.38
- RAPP 0.00
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.